Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Verheijen

Showing results (901-910 of 1,005) with videos related to

Pageof 101
Sort By:
Therapeutic Drug Monitoring|October 1, 2019
Therapeutic Drug Monitoring of Oral Anticancer Drugs: The Dutch Pharmacology Oncology Group-Therapeutic Drug Monitoring Protocol for a Prospective StudyStefanie L Groenland, Ruben A G van Eerden, Remy B Verheijen, et al.
Cancer Research|July 9, 2009
Biochemical, cellular, and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycinKer Yu, Lourdes Toral-Barza, Celine Shi, et al.
Gynecologic Oncology|November 29, 2011
Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancerD Cibula, N R Abu-Rustum, L Dusek, et al.
Gynecologic Oncology|September 11, 2014
The increased detection of cervical intraepithelial neoplasia when using a second biopsy at colposcopyJ van der Marel, R van Baars, A Rodriguez, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 9, 2020
Safety and efficacy of the cystic fibrosis transmembrane conductance regulator potentiator icenticaftor (QBW251)Shamsah Kazani, David J Rowlands, Ivan Bottoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2005
Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancerJoanna B Madalinska, Judith Hollenstein, Eveline Bleiker, et al.
Lancet (London, England)|October 9, 2007
Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trialN W J Bulkmans, J Berkhof, L Rozendaal, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|February 6, 2014
The impact of human papillomavirus genotype on colposcopic appearance: a cross-sectional analysisJ van der Marel, R van Baars, W G V Quint, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 25, 2023
The fidelity of transcription in human cellsClaire Chung, Bert M Verheijen, Xinmin Zhang, et al.
The Lancet. Oncology|February 7, 2020
Osimertinib plus savolitinib in patients with EGFR mutation-positive, MET-amplified, non-small-cell lung cancer after progression on EGFR tyrosine kinase inhibitors: interim results from a multicentre, open-label, phase 1b studyLecia V Sequist, Ji-Youn Han, Myung-Ju Ahn, et al.
Pageof 101

Showing results (901-910 of 1,005) with videos related to

Sort By:
Pageof 101
Therapeutic Drug Monitoring|October 1, 2019
Therapeutic Drug Monitoring of Oral Anticancer Drugs: The Dutch Pharmacology Oncology Group-Therapeutic Drug Monitoring Protocol for a Prospective StudyStefanie L Groenland, Ruben A G van Eerden, Remy B Verheijen, et al.
Cancer Research|July 9, 2009
Biochemical, cellular, and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycinKer Yu, Lourdes Toral-Barza, Celine Shi, et al.
Gynecologic Oncology|November 29, 2011
Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancerD Cibula, N R Abu-Rustum, L Dusek, et al.
Gynecologic Oncology|September 11, 2014
The increased detection of cervical intraepithelial neoplasia when using a second biopsy at colposcopyJ van der Marel, R van Baars, A Rodriguez, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 9, 2020
Safety and efficacy of the cystic fibrosis transmembrane conductance regulator potentiator icenticaftor (QBW251)Shamsah Kazani, David J Rowlands, Ivan Bottoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2005
Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancerJoanna B Madalinska, Judith Hollenstein, Eveline Bleiker, et al.
Lancet (London, England)|October 9, 2007
Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trialN W J Bulkmans, J Berkhof, L Rozendaal, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|February 6, 2014
The impact of human papillomavirus genotype on colposcopic appearance: a cross-sectional analysisJ van der Marel, R van Baars, W G V Quint, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 25, 2023
The fidelity of transcription in human cellsClaire Chung, Bert M Verheijen, Xinmin Zhang, et al.
The Lancet. Oncology|February 7, 2020
Osimertinib plus savolitinib in patients with EGFR mutation-positive, MET-amplified, non-small-cell lung cancer after progression on EGFR tyrosine kinase inhibitors: interim results from a multicentre, open-label, phase 1b studyLecia V Sequist, Ji-Youn Han, Myung-Ju Ahn, et al.
Pageof 101